<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Immunopathogenic Role of Reactive Oxygen Species in Alzheimer Disease</title>
    <FirstPage>203</FirstPage>
    <LastPage>216</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Monireh</FirstName>
        <LastName>Mohsenzadegan</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Mirshafiey</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Reactive oxygen species (ROS) are produced in many normal and abnormal processes in humans, including atheroma, asthma, joint diseases, cancer, and aging. Basal levels of ROS production&#xA0; in&#xA0; cells&#xA0; could&#xA0; be&#xA0; related&#xA0; to&#xA0; several&#xA0; physiological functions&#xA0; including&#xA0; cell proliferation, apoptosis and homeostasis.
However, excessive ROS production above basal levels would impair and oxidize DNA, lipids, sugars and proteins and consequently result in dysfunction of these molecules within cells and finally cell death. A leading theory of the cause of aging indicates that free radical damage and oxidative stress play a major role in the pathogenesis of Alzheimer disease (AD). Because the brain utilizes 20% more oxygen than other tissues that also undergo mitochondrial respiration, the potential for ROS exposure increases.
In fact, AD has been demonstrated to be highly associated with cellular oxidative stress, including augmentation of&#xA0; protein&#xA0; oxidation, protein&#xA0; nitration, glycoloxidation and&#xA0; lipid peroxidation as well as accumulation of Amyloid &#x3B2; (A&#x3B2;). The treatment with anti-oxidant compounds can provide protection against oxidative stress and A&#x3B2; toxicity.
In this review, our aim was to clarify the role of ROS in pathogenesis of AD and will discuss therapeutic efficacy of some antioxidants studies in recent years in this disease.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/561</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/561/493</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The in vitro Effect of Oxidized LDL and PHA on Proliferation and Gene Expression of Regulatory T Cells in Patients with Atherosclerosis</title>
    <FirstPage>217</FirstPage>
    <LastPage>223</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Azadeh</FirstName>
        <LastName>Mottaghi</LastName>
        <affiliation locale="en_US">Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Eisa</FirstName>
        <LastName>Salehi</LastName>
        <affiliation locale="en_US">Department of Immunology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hashem</FirstName>
        <LastName>Sezavar</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Division of Cardiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Ali</FirstName>
        <LastName>Keshavarz</LastName>
        <affiliation locale="en_US">Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Eshraghian</LastName>
        <affiliation locale="en_US">Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran AND&#xA0;&#xA0;Department of Immunology, Molecular Immunology Research Center; School of Medicine,Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Leili</FirstName>
        <LastName>Rejali</LastName>
        <affiliation locale="en_US">Cellular and Molecular Biology, Medical Branch, Tehran Azad University, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali-Akbar</FirstName>
        <LastName>Saboor-Yaraghi</LastName>
        <affiliation locale="en_US">Department of Nutrition and Biochemistry, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Atherosclerosis is a chronic inflammatory condition that affects the arterial wall. Oxidized low- density lipoprotein (ox-LDL) seems to have an important role in atherosclerotic plaque formation.
This study was performed to investigate the effects of ox-LDL as well as PHA on proliferation and gene expression of&#xA0; peripheral blood&#xA0; mononuclear&#xA0; cells (PBMCs) in patients with atherosclerosis compared&#xA0; to&#xA0; healthy controls. Proliferation of&#xA0; PBMCs was assessed by BrdU assay, while gene expression was assessed by real-time PCR.
Both PHA and ox-LDL significantly induced proliferation of PBMCs of patients and controls. PBMCs&#xA0; from&#xA0; controls&#xA0; showed&#xA0; significantly higher&#xA0; proliferation&#xA0; when&#xA0; stimulated&#xA0; with&#xA0; ox-LDL compared to patients. Expression of TGF-&#x3B2; was significantly lower in PBMCs from patients compared to healthy controls (p&lt;0.001). Following simulation with PHA, TGF-&#x3B2; and Foxp3 gene expression levels in patients and controls were significantly decreased (p&lt;0.001). Expression of Foxp3 in PBMCs treated with ox-LDL was significantly decreased in patients and controls.
Decreased expression of TGF-&#x3B2; and Foxp3 genes after ox-LDL stimulation may be due to more sensitivity of Treg cells than effector T cells to ox-LDL. Presence of ox-LDL within atheroma could be associated with the diminished population of Treg cells in the atherosclerotic patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/560</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/560/481</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association of Single Nucleotide Polymorphisms in the Human Tumor Necrosis Factor-&#x3B1; and Interleukin 1-&#x3B2; Genes in Patients with Pre-eclampsia</title>
    <FirstPage>224</FirstPage>
    <LastPage>229</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Farnaz</FirstName>
        <LastName>Mohajertehran</LastName>
        <affiliation locale="en_US">Department of Genetics, Ghaem Hospital, University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jalil</FirstName>
        <LastName>Tavakkol Afshari</LastName>
        <affiliation locale="en_US">Department of Immunogenetic &amp;amp; Tissue Culture, Immunology Research Center, Bu Ali Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Rezaieyazdi</LastName>
        <affiliation locale="en_US">Rheumatic Diseases Research Center, Ghaem Hospital, Faculty of Medicine, University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nayereh</FirstName>
        <LastName>Ghomian</LastName>
        <affiliation locale="en_US">Women Health Research Center, Imam Reza Hospital, Faculty of Medicine, University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Pre-eclampsia is a pregnancy-specific syndrome that may be dangerous especially to the&#xA0;fetus. Different cytokines have been found to be elevated in women with pre-eclampsia and&#xA0;may have possible roles in the development of this disorder. Alleles of the interleukin-l-beta&#xA0;(IL-l&#x3B2;) and tumor necrosis factor alpha (TNF-&#x3B1;) genes are associated with pr-eeclampsia in&#xA0;several studies in different populations. The aim of the present study was to investigate the&#xA0;relationship between IL-l&#x3B2; (C+3954T) and TNF-&#x3B1; (G-308A) gene polymorphisms with preeclampsia in north east of Iran (Khorasan province).&#xA0;
This study included 54 diagnosed patients with pre-eclampsia and 50 normal pregnant&#xA0;women as control group. DNA was extracted from peripheral blood and the polymorphisms&#xA0;were determined by PCR-RFLP method. Data was analyzed using chi-square and Fisher&#x2019;s&#xA0;exact tests.
There was significant association between TNF-&#x3B1; (G-308A) genotype and pre-eclampsia&#xA0;(p=0.001) but we did not find any significant association between IL-l&#x3B2; (C+3954T) genotype&#xA0;and pre-eclampsia (p=0.39).
The present study might suggest a role for TNF-&#x3B1; in the development of pre-eclampsia;&#xA0;however, IL-l&#x3B2; (C+3954T) polymorphism could not be considered as a marker of&#xA0;susceptibility to preeclampsia in our population.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/559</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/559/482</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Fish Consumption, Fish Atopy and Related Heavy Metals in Childhood Eczema</title>
    <FirstPage>230</FirstPage>
    <LastPage>235</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Kam Lun</FirstName>
        <LastName>Hon</LastName>
        <affiliation locale="en_US">Department of Paediatrics, Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China.</affiliation>
      </Author>
      <Author>
        <FirstName>Heike</FirstName>
        <LastName>Lui</LastName>
        <affiliation locale="en_US">Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China</affiliation>
      </Author>
      <Author>
        <FirstName>Shuxin Susan</FirstName>
        <LastName>Wang</LastName>
        <affiliation locale="en_US">Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hugh Simon</FirstName>
        <LastName>Lam</LastName>
        <affiliation locale="en_US">Department of Chemical Pathology, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ting Fan</FirstName>
        <LastName>Leung</LastName>
        <affiliation locale="en_US">Department of Pediatrics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong SAR, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Due to increasing worldwide water pollution, fish might be a source of excessive zinc, mercury, arsenic or&#xA0; manganese&#xA0; intake. The&#xA0; aim&#xA0; of&#xA0; this&#xA0; study&#xA0; was&#xA0; to&#xA0; evaluate if&#xA0; fish atopy/sensitization and fish consumption behavior are associated with eczema severity and blood levels of the 4 heavy metals.
One-hundred and nineteen patients with eczema and 43 patients with miscellaneous non-eczema&#xA0; skin&#xA0; diseases were&#xA0; studied.&#xA0; There&#xA0; were&#xA0; no&#xA0; differences&#xA0; in&#xA0; average weekly fish consumption&#xA0; and blood&#xA0; levels of&#xA0; the&#xA0; 4 heavy metals between eczema and&#xA0; non-eczema groups.
Blood levels of these metals were generally within the upper limits of local reference ranges in all these patients. In eczema patients, freshwater fish consumption&#xA0; behavior in days-per-week was correlated with blood arsenic and mercury levels (rho=0.17, p&lt;0.01 for both&#xA0; metals), but not&#xA0; with zinc or manganese. Levels of arsenic and mercury were also correlated with days of seawater fish consumption per week (arsenic: 0.38, mercury: 0.24, p &lt;0.05).
Fish&#xA0; sensitization was present&#xA0; in&#xA0; 25%&#xA0; of&#xA0; patients&#xA0; with eczema. Nevertheless,&#xA0; there was no&#xA0; difference in&#xA0; terms&#xA0; of&#xA0; fish&#xA0; consumption&#xA0; behavior, eczema severity, quality of life, and&#xA0; heavy metal levels between eczema patients&#xA0; with or&#xA0; without&#xA0; fish sensitization. We&#xA0; conclude&#xA0; that&#xA0;&#xA0; without&#xA0;&#xA0; exceeding&#xA0; local&#xA0; normal&#xA0; reference&#xA0; ranges,&#xA0; blood&#xA0;&#xA0; arsenic and&#xA0; mercury&#xA0; levels correlated&#xA0; with&#xA0; fish&#xA0; consumption&#xA0; behavior.&#xA0; There&#xA0; is&#xA0; no&#xA0; evidence to&#xA0;&#xA0; suggest&#xA0; that&#xA0;&#xA0; fish&#xA0; sensitization&#xA0; is&#xA0; associated&#xA0; with&#xA0; more&#xA0; severe&#xA0; eczema&#xA0; (bad&#xA0; for eczema), or that patients have milder eczema with more days of fish consumption (good for eczema).</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/558</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/558/484</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Efficacy of Atorvastatin and Antihistamines in Comparison with Antihistamines plus Placebo in the Treatment of Chronic Idiopathic Urticaria: A Controlled Clinical Trial</title>
    <FirstPage>236</FirstPage>
    <LastPage>240</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fakhrozaman</FirstName>
        <LastName>Pezeshkpoor</LastName>
        <affiliation locale="en_US">Research Center for Skin Diseases and Cutaneous Leishmaniasis, Ghaem Hospital, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Farid Hosseini</LastName>
        <affiliation locale="en_US">Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Houshang</FirstName>
        <LastName>Rafatpanah</LastName>
        <affiliation locale="en_US">Inflammation Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Behzad</FirstName>
        <LastName>Shakerian</LastName>
        <affiliation locale="en_US">Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Farahzad</FirstName>
        <LastName>Jabbari</LastName>
        <affiliation locale="en_US">Allergy Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Zandkarimi</LastName>
        <affiliation locale="en_US">Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hadis</FirstName>
        <LastName>Yousefzadeh</LastName>
        <affiliation locale="en_US">PhD Student of Immunology, Student Research Assembly of MUMS, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Homa</FirstName>
        <LastName>Sadri</LastName>
        <affiliation locale="en_US">Allergy Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abdolazim</FirstName>
        <LastName>Bahrami</LastName>
        <affiliation locale="en_US">Immunology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ali</FirstName>
        <LastName>Zamani</LastName>
        <affiliation locale="en_US">Inflammation Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Chronic Idiopathic Urticaria is defined as recurrent hives occurring for at least 6 weeks. In&#xA0; the&#xA0; majority of&#xA0; cases, there&#xA0; is no&#xA0; identifiable underlying etiology despite&#xA0; extensive evaluation. A subset of these patients is classified as having autoimmune urticaria defined by the presence of a functional IgG antibody to the &#x3B1; subunit of the high-affinity IgE receptor (FceRIa) or to IgE. The aim of this study was to evaluate the effects of the drug atorvastatin in patients with chronic urticaria compared to the placebo.
In this single-blind study, 50 patients suffering from chronic urticaria (15-45 years old) were selected and divided into two groups by simple randomization method. The first group was treated with atorvastatin and antihistamines and the second group (control group) was treated with placebo and antihistamines for 3 months. Urticaria severity was measured by score index, before and after the treatment course: ASST (Autologous serum skin test) was performed for all patients and sera were collected to measure cytokines.
In cases, IL-5 decreased and IL-10 increased after treatment compared to the time point before&#xA0; treatment&#xA0; (p&lt;0.05). All patients with severe utricaria according our&#xA0; scoring, had positive ASST.
The patients with severe urticaria identified by urticaria score and ASST positivity had chronic idiopathic urticaria. By prescribing the Atorvastatin plus antihistamines in severe and resistant forms of urticaria, the use of more toxic medications like cytotoxic drugs may be avoided.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/557</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/557/485</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>11</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2012</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Association between Anti-Thyroid Peroxidase Antibody and Asthma in Women</title>
    <FirstPage>241</FirstPage>
    <LastPage>245</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mitra</FirstName>
        <LastName>Samareh Fekri</LastName>
        <affiliation locale="en_US">Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Shokoohi</LastName>
        <affiliation locale="en_US">Research Center for Modeling in Health, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad-Hossein</FirstName>
        <LastName>Gozashti</LastName>
        <affiliation locale="en_US">Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>Esmailian</LastName>
        <affiliation locale="en_US">Research Committee, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nasrollah</FirstName>
        <LastName>Jamshidian</LastName>
        <affiliation locale="en_US">Research Committee, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Malihe</FirstName>
        <LastName>Shadkam-Farokhi</LastName>
        <affiliation locale="en_US">Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad-Reza</FirstName>
        <LastName>Lashkarizadeh</LastName>
        <affiliation locale="en_US">Department of Thoracic Surgery; Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Malekpour Afshar</LastName>
        <affiliation locale="en_US">Physiology Research Center, Kerman University of Medical Sciences, Kerman, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>16</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">About 8% of the general population suffers from autoimmune diseases, from which 78% are women. One of the most important causes of thyroid diseases is autoimmunity in origin, and it seems that people with thyroid diseases present more signs of asthma. This study was therefore designed to investigate the frequency of autoimmune thyroid diseases in women sufferiR (maximum heart rate) for evaluating EIA. Pulmonary function tests (PFT) were measured before (baseline), immediately, 5 minutes and 15 minutes after exercise.
The prevalence of asthma symptoms among the studied students was 12.54%. There was not&#xA0; significant difference in any of PFT&#xA0; values between asymptomatic and symptomatic students. The results of exercise test showed that totally 61.22% of symptomatic students responded to exercise test (their post-exercise PFT values decline more than 15%) while only 16.82% of asymptomatic students were responders to exercise (p&lt;0.001). However, in both asymptomatic and symptomatic responder&#xA0; students,&#xA0; all PFT&#xA0; values declined significantly after exercise compared&#xA0; to&#xA0; baseline values (p&lt;0.05 to&#xA0; p&lt;0.001) and&#xA0; there&#xA0; was not&#xA0; any significant difference between two groups.
The results showed that although higher number of symptomatic students showed EIA, some asymptomatic students also sowed EIA.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/320</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/320/320</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>10</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2011</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Immunomodulatory Effects of Astragalus gypsicolus Hydroalcoholic Extract in Ovalbumin-Induced Allergic Mice Model</title>
    <FirstPage>281</FirstPage>
    <LastPage>288</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mehri</FirstName>
        <LastName>Ghafourian Boroujerdnia</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Ebrahim</FirstName>
        <LastName>Azemi</LastName>
        <affiliation locale="en_US">Medicinal Plant Research Center, Department of Pharmacognosy, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Asghar</FirstName>
        <LastName>Hemmati</LastName>
        <affiliation locale="en_US">Department of Parmacology, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Amin</FirstName>
        <LastName>Taghian</LastName>
        <affiliation locale="en_US">School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Azadmehr</LastName>
        <affiliation locale="en_US">Immunology Division, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Several studies have demonstrated that herbal extracts possess various biological effects including anti-inflammatory and&#xA0; anti-cancer&#xA0; activities. The&#xA0; present&#xA0; study&#xA0; was aimed to investigate the protective effects of the Astragalus gypsicolus&#xA0; (AG) hydroalcoholic extract in early allergic sensitized mice induced by ovalbumin.
Phytochemical assay was used&#xA0; to&#xA0; recognize the&#xA0; main active constituents&#xA0; in the&#xA0; AG hydroalcoholic extract. Mice were immunized with subcutaneous injection of ovalbumin and aluminum hydroxide. Efficiency of&#xA0; sensitization was assessed by serum&#xA0; IgE&#xA0; levels and eosinophil count. After sensitization, two doses of extract (250 mg/kg and 500 mg/kg) were injected intrapritoneally.
On&#xA0; day 14, mice were challenged with intrapritoneal injection of ovalbumin. IL-4 and IFN&#x3B3;&#xA0; levels in&#xA0; broncoalveolar&#xA0; lavage fluid, which had&#xA0; been&#xA0; collected on&#xA0; day 15, were assessed by Enzyme-Linked Immunosorbent Assay (ELISA) kit.
Our results indicate two main active constituents including flavonoids and terpenoids are present in the AG hydroalcoholic extract. Intrapritoneal injection of the AG hydroalcoholic extract was able to decrease IL-4 and increase IFN&#x3B3;. It seems the AG hydroalcoholic extract has the potential to modulate the balance of Th1/Th2 cytokines in allergy.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/321</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/321/321</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>10</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2011</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Oral and Dental Health Status in Patients with Primary Antibody Deficiencies</title>
    <FirstPage>289</FirstPage>
    <LastPage>293</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ghasem</FirstName>
        <LastName>Meighani</LastName>
        <affiliation locale="en_US">Department of Pediatrics Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Asghar</FirstName>
        <LastName>Aghamohammadi</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Honarmand</FirstName>
        <LastName>Javanbakht</LastName>
        <affiliation locale="en_US">Department of Pediatrics Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Abolhassani</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sina</FirstName>
        <LastName>Nikayin</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Mehryar</FirstName>
        <LastName>Jafari</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Ghandehari Motlagh</LastName>
        <affiliation locale="en_US">Department of Pediatrics Dentistry, School of Dentistry, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad Reza</FirstName>
        <LastName>Shamshiri</LastName>
        <affiliation locale="en_US">Faculty of public Health and Institute of Health Research, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran AND Molecular Immunology Research Center; and Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Primary antibody deficiencies (PAD) are a group of immune system disorders, associated with decreased levels of secretory and protective immunoglobulins. Because of the important role of immunoglobulins in the protection&#xA0; of oral cavity, patients with PADs&#xA0; are more susceptible to dental caries or oral manifestations.
This study was performed&#xA0; to investigate the oral and dental manifestations of PADs patients. In this study, 33 patients with PADs (21 common variable immunodeficiency, 8 X- linked agammaglobulinemia and 4 hyper IgM syndrome) and 66 controls were examined; the number of decayed, missed and filled teeth (DMFT) were investigated.
Aphthous&#xA0; was the most frequent manifestation in PADs patients (38.7%), which wassignificantly16.7% higher than&#xA0; the&#xA0; controls&#xA0; (p=0.03). The&#xA0; patients&#xA0; with&#xA0; PADs&#xA0; showed significantly higher presentation of other oral and dental manifestations, including herpes sores, candidiasis tonsillitis, gingivitis, calculus, enamel hypoplasia and other ulcerations. The mean DMFT scores were 6.15&#xB1;3.6 and 1.93&#xB1;0.4 in PADs patients and controls, respectively (p&lt;0.001). Although the patients with common variable immunodeficiency had higher means of DMFT in comparison with other groups of PADs, this difference was not statistically significant.
This study showed significantly higher frequency of oral and dental manifestations in the patients with PADs&#xA0; compared to controls. Therefore, regular examination of oral cavity could be suggested in this group of immunodeficient patients.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/322</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/322/322</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>10</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2011</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Normal Range Determination of Lymphocytes Subsets in Normal Adults in Iran</title>
    <FirstPage>295</FirstPage>
    <LastPage>298</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Shokouhi Shoormasti</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Anahita</FirstName>
        <LastName>Azimdoost</LastName>
        <affiliation locale="en_US">Department of Immunology and Allergy, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Shiva</FirstName>
        <LastName>Saghafi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Masood</FirstName>
        <LastName>Movahhedi</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Taghi</FirstName>
        <LastName>Haghi Ashtiani</LastName>
        <affiliation locale="en_US">Clinical and Anatomical Pathology, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Pourpak</LastName>
        <affiliation locale="en_US">Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran AND Department of Immunology and Allergy, Children Medical Center, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Bagher</FirstName>
        <LastName>Eslami</LastName>
        <affiliation locale="en_US">Department of Immunology, Public Health Faculty, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Immunophenotyping of lymphocytes is very essential for evaluation of immune system. Due&#xA0; to&#xA0; the&#xA0; effect&#xA0; of&#xA0; environmental&#xA0; factors&#xA0; and&#xA0; ethnical diversity on&#xA0; immune&#xA0; system, establishment of an internal normal range of lymphocyte subsets is a necessity for each population.&#xA0; The&#xA0; aim&#xA0; of&#xA0; this&#xA0; study&#xA0; was&#xA0; to&#xA0; determine&#xA0; the&#xA0; normal&#xA0; range&#xA0; of&#xA0; T&#xA0; and&#xA0; B lymphocytes, and NK cells in normal Iranian adults.
Two hundred and thirty three Iranian normal adult volunteers took part in this study. Complete Blood Count (CBC) was performed for them with Sysmex (KX21) and cells with CD3, CD4, CD8, CD19 and CD16/56&#xA0; surface markers were simultaneously detected by flow cytometry method&#xA0; with FACstar system. Their percentile and absolute count&#xA0; were determined.
The&#xA0; volunteers&#xA0; were&#xA0; 150&#xA0; male&#xA0; and&#xA0; 83&#xA0; female.&#xA0; Mean&#xA0; percentages&#xA0; of&#xA0; lymphocyte subpopulation were: CD3 (67.66 &#xB1;7.76), CD19 (14.41&#xB1;5.09), CD4 (39.22&#xB1;6.7), CD8 (25.42&#xB1;5.4) and CD16/56 (10.14&#xB1;6.42). Also, their mean absolute count of lymphocyte bearing CD3, CD19, CD4 and CD8 were 1,504&#xB1;505/&#xB5;l, 332&#xB1;186/&#xB5;l, 827&#xB1;313/&#xB5;l and 522&#xB1;185/&#xB5;l, respectively.
Our results are comparable with similar Asian results from other Asian population, but are different from European population, we therefore conclude that it is necessary for each laboratory to establish an internal normal range for the lymphocytes bearing above- mentioned markers.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/323</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/323/323</pdf_url>
  </Article>
  <Article>
    